Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis
β Scribed by Oscar Arrieta; Jose Luis Rodriguez-Diaz; Vanessa Rosas-Camargo; Daniela Morales-Espinosa; Sergio Ponce de Leon; David Kershenobich; Eucario Leon-Rodriguez
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 112 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Chronic hepatitis C can result in fatty changes in the liver. Previous studies have suggested that hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus (HCV) infection. The authors sought to determine whether hepatic steatosi
## BACKGROUND. The effect of prior hepatitis B virus (HBV) infection on the clinicopathologic findings for patients with hepatitis C virus (HCV) RNA and hepatocellular carcinoma (HCC) is still unclear. ## METHODS. Of 59 patients who underwent liver resection for HCV-related HCC (Υ 2.0 cm in greate
## Background: The optimal treatment for hepatocellular carcinoma (hcc) is surgical resection. however, only a small percentage of patients are operative candidates. percutaneous radiofrequency interstitial thermal ablation proved to be effective, too. our objective was to assess a novel operative